6,972
Total Number of Employees
36%
Employees involved in R&D and Quality
5
R&D Centers
300+
Clients Served
6
Innovators
Dear Laurus Labs Family members & Stakeholders,
As we stand at the forefront of innovation and progress, I want to express my gratitude for the collective efforts that define our journey at Laurus Labs.
From pioneering pharmaceutical breakthroughs to championing sustainability and empowering communities, our commitment goes beyond business metrics. We are architects of positive change, creators of a legacy that extends beyond profits.
In the realm of healthcare, we are not just providers of medication; we are enablers of healing. Our endeavours reach beyond borders, making a tangible impact on individuals facing health challenges.
Our dedication to education echoes in the initiatives that nurture young minds, providing access to knowledge for a brighter future. In every action, we sow the seeds of growth and empowerment.
Environmental stewardship is ingrained in our DNA. Our green initiatives and pollution control programs reflect a profound understanding of our responsibility toward the planet.
As we move forward, let us continue to push boundaries, embrace innovation, and foster a culture where every effort contributes to a holistic legacy. Together, we are not just a company; we are architects of a future that prioritizes progress, compassion, and sustainable growth.
Thank you for being an integral part of this extraordinary journey.
Satyanarayana Chava
Founder & CEO
Since our inception in 2005, we have been developing and manufacturing Active Pharmaceutical Ingredients (APIs) and Intermediates. We quickly scaled our pharmaceutical value chain by attaining a global leadership position in APIs, including anti-retroviral (ARV), Oncology, Cardiovascular, and Gastro therapeutics. Our position was strengthened by our backward-integration capability while remaining highly regulatory compliant across all operations.
As our portfolio of pharmaceutical Ingredients & Finished Dosages was strengthened, in line with our vision, Laurus Labs extended its development and manufacturing solutions to multiple large pharmaceutical organizations.
As our portfolio of pharmaceutical Ingredients & Finished Dosages was strengthened, in line with our vision, Laurus Labs extended its development and manufacturing solutions to multiple large pharmaceutical organizations.
We emerged as one of the most trusted and largest pharmaceutical Contract Development & Manufacturing Organizations (CDMO) in India for both generics and the proprietary space.
While small-molecule chemistry is ingrained in our DNA, Laurus Labs recognizes the potential and differential benefits of large molecules, namely biologicals and biotechnology products, in the healthcare and nutritional space. We permeated this domain with the inception of Laurus Bio and continue the commitment by investing and collaborating in Cell and Gene therapies.
As a company, we are committed to conducting our business with utmost transparency, integrity, and responsibility towards our employees, society, customers, and all our stakeholders. We consciously and consistently strive to achieve our sustainable development goals, as showcased in our Environmental, Social, and Governance (ESG) focus and performance.
These compounding factors enable us to employ and retain the best talent while maintaining unabated trust from our customers and other stakeholders. Given that we operate in a highly regulated sector, we adopt a high-watermark approach for compliance to ensure that we exceed all requirements for applicable international standards.
Total Number of Employees
Employees involved in R&D and Quality
R&D Centers
Clients Served
Innovators
Reactor Volumes
tabs/caps Formulations (OSD)
Launches across Drug Product (DP) & Drug Substance (DS)
Quality Audits
Manufacturing Sites
Patents Granted
Revenue; +9% Expo Delivery
16% EBITDA Margin
Capex; 14% of Revenues
ROCE
Net Profit
R&D Spend as a % of Sales